Atlas Trials

Avanz Phleum Pratense Maintenance Dose

Clinical trial NCT01438827 · COMPLETED

Trial details

NCT number
NCT01438827
Sponsor
ALK-Abelló A/S
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Allergic Rhinoconjunctivitis
Start date
2011-09-01
Primary completion
2012-12-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.